Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets

Clinical trial NCT05576584 · UNKNOWN

Trial details

NCT number: NCT05576584
Sponsor: Fujian Akeylink Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Food Affect Single Ascending Dose Maximum Applicable Dose

Start date: 2022-07-19
Primary completion: 2023-12-28
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.